2-Arachidonoylglycerol Activity in Over Ischemia Reperfusion Damage: Can Endocannabinoids Protect Ovarian Reserve?
Cannabis and Cannabinoid Research · 2024
DOI: 10.1089/can.2022.0242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Demet Aydogan Kirmizi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, and Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey. Hauptthemen laut MEDLINE: Ovarian Reserve, Reperfusion Injury, Arachidonic Acids, Glycerides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, and Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
- Department of Obstetrics and Gynecology, Pamukkale University, Denizli, Turkey.
ORCID-Profile: Emre Başer
Zitieren
APA
Aydogan Kirmizi, D., Başer, E., Kaymak, E., Kılıc, D., Onat, T., & Ozkut, M. M. (2024). 2-Arachidonoylglycerol Activity in Over Ischemia Reperfusion Damage: Can Endocannabinoids Protect Ovarian Reserve?. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0242
Vancouver
Aydogan Kirmizi D, Başer E, Kaymak E, Kılıc D, Onat T, Ozkut MM. 2-Arachidonoylglycerol Activity in Over Ischemia Reperfusion Damage: Can Endocannabinoids Protect Ovarian Reserve?. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2022.0242
BibTeX
@article{AydoganKirmizi2024,
author = {Aydogan Kirmizi, Demet and Başer, Emre and Kaymak, Emin and Kılıc, Derya and Onat, Taylan and Ozkut, Mahmud Mustafa},
title = {2-Arachidonoylglycerol Activity in Over Ischemia Reperfusion Damage: Can Endocannabinoids Protect Ovarian Reserve?},
journal = {Cannabis and Cannabinoid Research},
year = {2024},
doi = {10.1089/can.2022.0242}
}
EUVIMED